Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Hanlim Moon

4PUBLICATIONS

6CO-AUTHORS

Toxicology (incl. clinical toxicology)PharmacogenomicsMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Apr 13, 2026

Erratum: A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025.

Seoyoung Koo, Chae Yeon Kim, Jeong Hyeon Lim

|Jan 19, 2026

A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025.

Seoyoung Koo, Chae Yeon Kim, Jeong-Hyeon Lim

|Jul 30, 2024

FDA regulatory considerations for oncology drug development.

Hanlim Moon, Dae Young Zang, Min-Hee Ryu

|Jul 08, 2022

FDA initiatives to support dose optimization in oncology drug development: the less may be the better.

Hanlim Moon

Pageof 1

Frequent Collaborators

2 joint publications

Seoyoung Koo

1 joint publications

Dae Young Zang

1 joint publications

Min-Hee Ryu

1 joint publications

YeonSook Seo

1 joint publications

Bitna Oh

1 joint publications

Lee Farrand

Frequent Collaborators

2 joint publications

Seoyoung Koo

1 joint publications

Dae Young Zang

1 joint publications

Min-Hee Ryu

1 joint publications

YeonSook Seo

Top Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on : Mar 08, 2018

FDA Approved Drugs: Changes to Approved Drugs

FDA Approved Drugs: Changes to Approved Drugs

Published on : Oct 03, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos

Top Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on : Mar 08, 2018

FDA Approved Drugs: Changes to Approved Drugs

FDA Approved Drugs: Changes to Approved Drugs

Published on : Oct 03, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos